These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36869284)

  • 1. CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization using random forest models.
    An H; Bhatia I; Cao F; Huang Z; Xie C
    BMC Cancer; 2023 Mar; 23(1):201. PubMed ID: 36869284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.
    Shi ZX; Li CF; Zhao LF; Sun ZQ; Cui LM; Xin YJ; Wang DQ; Kang TR; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):361-369. PubMed ID: 37429785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Cheng S; Hu G; Jin Z; Wang Z; Xue H
    Eur Radiol; 2023 Dec; 33(12):8715-8726. PubMed ID: 37436507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE).
    Mao X; Guo Y; Wen F; Liang H; Sun W; Lu Z
    Cancer Imaging; 2021 Aug; 21(1):49. PubMed ID: 34384496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Park C; Kim JH; Kim PH; Kim SY; Gwon DI; Chu HH; Park M; Hur J; Kim JY; Kim DJ
    Korean J Radiol; 2021 Feb; 22(2):213-224. PubMed ID: 32901464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
    Kim J; Choi SJ; Lee SH; Lee HY; Park H
    AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models.
    Vosshenrich J; Zech CJ; Heye T; Boldanova T; Fucile G; Wieland S; Heim MH; Boll DT
    Eur Radiol; 2021 Jun; 31(6):4367-4376. PubMed ID: 33274405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the prognosis of hepatocellular carcinoma with the treatment of transcatheter arterial chemoembolization combined with microwave ablation using pretreatment MR imaging texture features.
    Liu J; Pei Y; Zhang Y; Wu Y; Liu F; Gu S
    Abdom Radiol (NY); 2021 Aug; 46(8):3748-3757. PubMed ID: 33386449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography texture analysis combined with preoperative clinical factors serve as a predictor of early efficacy of transcatheter arterial chemoembolization in hepatocellular carcinoma.
    Fan XL; Wang YH; Chen YH; Chen BX; Cai JN; Yang JS; Sun X; Yan FR; He BS
    Abdom Radiol (NY); 2023 Jun; 48(6):2008-2018. PubMed ID: 36943423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic nomogram for hepatocellular carcinoma patients after transarterial chemoembolization based on des-γ-carboxy prothrombin reactivity and modified Response Evaluation Criteria in Solid Tumors.
    Zhao SM; Qiu LW; Zhao H; Gu WW; Yang XH; Gu ZX; Shi RF; Ni CF
    J Cancer Res Ther; 2021 Jul; 17(3):707-714. PubMed ID: 34269303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients.
    Chen C; Qiu H; Yao Y; Zhang Z; Ma C; Ma Y; Zhao C; Xiang H; Zhao H; Zheng C; Xiong B; Li H; Long Q; Zhou J; Luo C; Hu H
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101460. PubMed ID: 32593695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Jeong Y; Yoon SM; Han S; Shim JH; Kim KM; Lim YS; Lee HC; Kim SY; Park JH; Lee SW; Ahn SD; Choi EK; Kim JH
    PLoS One; 2015; 10(8):e0135298. PubMed ID: 26252472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
    He CB; Lao XM; Lin XJ
    Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
    Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
    Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
    BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).
    Ma W; Jia J; Wang S; Bai W; Yi J; Bai M; Quan Z; Yin Z; Fan D; Wang J; Han G
    Theranostics; 2014; 4(7):736-44. PubMed ID: 24883123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of texture analysis in evaluating liver cancer recurrence after transarterial chemoembolization].
    Wang R; Yang XY; Wang KY; Wang S; Li Q; Wu JF; Xu HT; Dai Y; Han CP; Xu K; Chen GH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):200-204. PubMed ID: 28482407
    [No Abstract]   [Full Text] [Related]  

  • 20. Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma.
    Chen L; Kan X; Sun T; Ren Y; Cao Y; Yan L; Liang B; Xiong B; Zheng C
    BMC Gastroenterol; 2020 Jun; 20(1):205. PubMed ID: 32600349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.